Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.

doi:10.1016/j.ygyno.2011.04.004

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.

Gynecologic oncology - 1 Aug 2011

Chapman Jocelyn S, Powell C Bethan, McLennan Jane, Crawford Beth, Mak Julie, Stewart Nicola, Chen Lee-May

Abstract excerpt

OBJECTIVES: To characterize the post-operative care of BRCA1 and BRCA2 mutation carriers who undergo risk-reducing salpingo-oophorectomy (RRSO). METHODS: BRCA1 and BRCA2 mutation carriers from our Cancer Risk Program who elected RRSO were sent questionnaires regarding their post-surgical surveillance and treatment for menopause symptoms, primary peritoneal cancer and bone loss. RESULTS: In 51 mutation carriers...

Topics

Adult
Aged
Bone Density
CA-125 Antigen
Estrogen Replacement Therapy
Fallopian Tubes
Female
Follow-Up Studies
Genes, BRCA1
Genes, BRCA2
Heterozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Humans

Middle Aged

Mutation

Ovarian Neoplasms

Ovariectomy

Survivors

Source

Open in PubMed

Identifiers

PMID: 21531449
DOI: 10.1016/j.ygyno.2011.04.004

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.PMID 21531449Read ↗

The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.Semantic proximity Read ↗

Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.Semantic proximity Read ↗

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.Semantic proximity Read ↗

Managing symptoms and maximizing quality of life after preventive interventions for cancer risk reduction.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Semantic proximity Read ↗

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.Semantic proximity Read ↗

The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study.Semantic proximity Read ↗

Quality of life after risk-reducing salpingo-oophorectomy in women with a pathogenic BRCA variant.Semantic proximity Read ↗

Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.Semantic proximity Read ↗

Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.